Leishmania major infection of inbred mice: Unmasking genetic determinants of infectious diseases

BioEssays

Volumn 21, Issue 6, 1999, Pages 510-518

  Fowell, Deborah J ^a   Locksley, Richard M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; COMMUNICABLE DISEASE; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOLOGY; LEISHMANIA MAJOR; MOUSE; MOUSE STRAIN; PARASITOLOGY; REVIEW; SKIN LEISHMANIASIS; T LYMPHOCYTE;

ANIMALS; COMMUNICABLE DISEASES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED STRAINS; T-LYMPHOCYTES;

ANIMALIA; LEISHMANIA MAJOR;

EID: 0033153448     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-1878(199906)21:6<510::AID-BIES7>3.0.CO;2-5     Document Type: Review

References (76)

1. Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol 1995;13:151-177.
2. Howard JG, Hale C, Liew FY. Immunological regulation of experimental cutaneous leishmaniasis. IV. Prophylactic effect of sublethal irradiation as a result of abrogation of suppressor T cell generation in mice genetically susceptible to Leishmania tropica. J Exp Med 1981;153:557-568.
3. Titus RG, Ceredig R, Cerottini JC, Louis JA. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. J Immunol 1985;135:2108-2114.
4. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med 1989;169:59-72.
5. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996;383:787-793.
6. Kelso A, Gough NM. Coexpression of granulocyte-macrophage colony-stimulating factor, γ interferon, and interleukins 3 and 4 is random in murine alloreactive T-lymphocyte clones. Proc Natl Acad Sci USA 1988;85: 9189-9193.
7. Miner KT, Croft M. Generation, persistence and modulation of Th0 effector cells: role of autocrine IL-4 and IFN-γ. J Immunol 1998;160:5280-5287.
8. Chen Y, Kuchroo VK, Inobe J-I, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994;265:1237-1240.
9. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-742.
10. + T cells. Immunol Cell Biol 1988;66:57-63.
11. Holaday BJ, Sadick MD, Wang Z-E, Reiner SL, Heinzel FP, Parslow TG, Locksley RM. Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines. J Immunol 1991;147:1653-1658.
12. Varkila K, Chatelain R, Leal LM, Coffman RL. Reconstitution of C.B-17 scid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection. Eur J Immunol 1993;23:262-268.
13. Locksley RM, Reiner SL, Hatam F, Littman DR, Killeen N. Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. Science 1993;261:1448-1451.
14. + T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis. Eur J Immunol 1987;17: 1429-1433.
15. + effector cells default to the Th2 pathway in interferon-γ-deficient mice infected with Leishmania major. J Exp Med 1994;179:1367-1371.
16. + T cell response. J Exp Med 1995;181:961-971.
17. Mattner F, Magram J, Ferrante J, Launois P, Di Padova K, Behin R, Gately MK, Louis JA, Alber G. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur J Immunol 1996;26:1553-1559.
18. Diefenbach A, Schindler H, Donhauser N, Lorenz E, Laskay T, MacMicking J, Rollinghoff M, Gresser I, Bogdan C. Type 1 interferon (IFN α/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 1998;8:77-87.
19. Aebischer T, Moody SF, Handman E. Persistance of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host. Infect Immun 1993;61:220-226.
20. Sadick MD, Heinzel FP, Holaday BJ, Pu RT, Dawkins RS, Locksley RM. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. J Exp Med 1990;171:115-127.
21. Guery J-C, Galbiati F, Smiroldo S, Adorini L. Selective development of T helper (Th) 2 cells induced by continuous administration of low dose soluble proteins to normal and β2-microglobulin-deficient BALB/c mice. J Exp Med 1996;183:485-496.
22. + T helper cell phenotype development in a T cell receptor-αβ transgenic model. J Exp Med 1995;182:1579-1584.
23. + T cells. J Exp Med 1995;182:1591-1596.
24. Kearney ER, Pape KA, Loh DY, Jenkins MK. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1994;1:327-339.
25. Gajewski TF, Pinnas M, Wong T, Fitch FW. Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. J Immunol 1991;146:1750-1758.
26. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998;8:275-283.
27. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 1992;257:539-542.
28. Howard JG, Hale C, Chan-Liew WL. Immunological regulation of experimental cutaneous leishmaniasis. 1. Immunogenetic aspects of susceptibility to Leishmania tropica in mice. Parasitol Immunol 1980;2:303-314.
29. Magram J, Connaughton SE, Warrer RR, Carvajal DM, Wu C-Y, Ferrante J, Stewart C, Sarmiento U, Faherty DA, Gately MK. IL-12-deficient mice are defective in IFN-γ production and type 1 cytokine responses. Immunity 1996;4:471-481.
30. Takeda K, Tsutsui H, Yoshimoto T, Adachi O, Yoshida N, Kishimoto T, Okarmura H, Nakanishi K, Akira S. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 1998;8:383-390.
31. Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethman H, Kohler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993;362:245-248.
32. Urban JF Jr, Noben-Trauth N, Donaldson DD, Madden KB, Morris SC, Collins M, Finkelman FD. IL-13, IL-4Rα, and stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity 1998;8:255-264.
33. Zhang M, Gately MK, Wang E, Gong J, Wolf SF, Lu S, Modlin RL, Barnes PF. Interleukin-12 at the site of disease in tuberculosis. J Clin Invest 1994;93:1733-1739.
34. + T cells through IL-12 produced by Listeria-induced macrophages. Science 1993;260:547-549.
35. Tripp CS, Wolf SF, Unanue ER. Interleukin-12 and tumor necrosis factor-α are costimulators of interferon-γ production by natural killer cells in servere combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci USA 1993;90:3725-3729.
36. Gazzinelli RT, Hieny S, Wynn TA, Wolf S, Sher A. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon-γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci USA 1993;90:6115-6119.
37. + T cells during initiation of infection. J Exp Med 1994;179:447-456.
38. Carrera L, Gazzinelli RT, Badolato R, Hieny S, Muller W, Kuhn R, Sacks DL. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J Exp Med 1996;183:515-526.
39. Scott B, Liblau R, Degermann S, Marconi LA, Ogata L, Caton AJ, McDevitt HO, Lo D. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1994;1:73-82.
40. Corry DB, Folkesson HG, Warnock ML, Erle DJ, Matthay MA, Wiener-Kronish JP, Locksley RM. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 1996;183:109-117.
41. Hsieh C-S, Macatonia SE, O'Garra A, Murphy KM. T cell genetic background determines default T helper phenotype development in vitro. J Exp Med 1995;181:713-721.
42. + T cell-intrinsic mechanism. J Exp Med 1998;188:2289-2299.
43. Guler ML, Gorham JD, Hsieh C-S, Mackey AJ, Steen RG, Dietrich WF, Murphy KM. Genetic susceptibility to Leishmania: IL-12 responsiveness in Th1 cell development. Science 1996;271:964-967.
44. Guler ML, Jacobson NG, Gubler U, Murphy KM. T cell genetic background determines maintenance of IL-12 signaling. J Immunol 1997;159: 1767-1774.
45. Wu C, Ferrante J, Gately MK, Magram J. Characterization of IL-12 receptor β1 chain (IL-12Rβ1)-deficient mice. J Immunol 1997;159:1658-1665.
46. Gorham JD, Guler ML, Steen RG, Mackey AJ, Daly MJ, Frederick K, Dietrich WF, Murphy KM. Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. Proc Natl Acad Sci USA 1996;93:12467-12472.
47. Lohoff M, Ferrick D, Mittrucker H-W, Duncan GS, Bischof S, Rollinghoff M, Mak TW. Interferon regulatory factor-1 is required for T helper 1 immune response in vivo. Immunity 1997;6:681-689.
48. Hattori N, Kawamoto H, Fujimoto S, Kuno K, Katsura Y. Involvement of transcription factors TCF-1 and GATA-3 in the initiation of the earliest step of T cell development in the thymus. J Exp Med 1996;184:1137-1147.
49. Demant P, Lipoldova M, Svobodova M. Resistance to Leishmania major in mice. Science 1996;274:1392-1393.
50. Beebe AM, Mauze S, Schork NJ, Coffman RL. Serial backcrossing mapping of multiple loci associated with resistance to Leishmania major in mice. Immunity 1997;6:551-557.
51. Shankar AH, Titus RG. T cell and non-T cell compartments can independently determine resistance to Leishmania major. J Exp Med 1995;181: 845-855.
52. Kopf M, Brombacher F, Kohler G, Kienzle G, Widmann K-H, Lefrang K, Humborg C, Ledermann B, Solbach W. IL-4-deficient BALB/c mice resist infection with Leishmania major. J Exp Med 1996;184:1127-1136.
53. Noben-Trauth N, Kropf P, Muller I. Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science 1996;271:987-990.
54. McKenzie GJ, Emson CL, Bell SE, Anderson S, Fallon P, Zurawski G, Murray R, Grencis R, McKenzie ANJ. Impaired development of Th2 cells in IL-13-deficient mice. Immunity 1998;9:423-432.
55. McInnes A, Rennick DM. Interleukin 4 induces cultured monocytes/ macrophages to form giant multinucleated cells. J Exp Med 1988;167:598-611.
56. Volpert OV, Fong T, Koch AE, Peterson JD, Waltenbaugh C, Tepper RI, Bouck NP. Inhibition of angiogenesis by interleukin 4. J Exp Med 1998;188:1039-1046.
57. Vella AT, Dow S, Potter TA, Kappler J, Marrack P. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc Natl Acad Sci USA 1998;95:3810-3815.
58. Gieni RS, Fang Y, Trinchieri G, Umetsu DT, DeKruyff RH. Differential production of IL-12 in BALB/c and DBA/2 mice controls IL-4 versus IFN-gamma synthesis in primed CD4 lymphocytes. Int Immunol 1996;8: 1511-1520.
59. Ma X, Chow JM, Gri G, Carra G, Gerosa F, Wolf SF, Dzialo R, Trinchieri G. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J Exp Med 1996;183:147-157.
60. Mougneau E, Altare F, Wakil AE, Zheng S, Coppola T, Wang Z-E, Waldmann R, Locksley RM, Glaichenhaus N. Expression cloning of a protective Leishmania antigen. Science 1995;268:563-566.
61. Reiner SL, Wang Z-E, Hatam F, Scott P, Locksley RM. Th1 and Th2 cell antigen receptors in experimental leishmaniasis. Science 1993;259:1457-1460.
62. Neer EJ, Schmidt CJ, Nambudripad R, Smith TF. The ancient regulatory-protein family of WD-repeat proteins. Nature 1994;371:297-300.
63. McConville MJ, Bacic A. The glycoinositolphospholipids profiles of two Leishmania major strains that differ in lipophosphoglycan expression. Mol Biochem Parasitol 1990;38:57-68.
64. Bouvier J, Etges RJ, Bordier C. Identification and purification of membrane and soluble forms of the major surface protein of Leishmania promastigotes. J Biol Chem 1985;260:15504-15509.
65. + T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 1997;6:541-549.
66. Sette A, Buus S, Colon S, Smith JA, Miles C, Grey HM. Structural characteristics of an antigen required for its interaction with la and recognition by T cells. Nature 1987;328:395-399.
67. Reiner SL, Fowell DJ, Moskowitz NH, Swier K, Brown DR, Brown CR, Turck CW, Scott PA, Killeen N, Locksley RM. Control of Leishmania major by a monoclonal αβ T cell repertoire. J Immunol 1998;160:884-889.
68. Julia V, Rassoulzadegan M, Glaichenhaus N. Resistance to Leishmania major induced by tolerance to a single antigen. Science 1996;274:421-423.
69. -. Eur J Immunol 1995;25:3298-3307.
70. + T cells are not esential for T helper cell 2 immune responses. J Exp Med 1996;184: 1295-1304.
71. - T cell population. J Immunol 1996;157:4421-4427.
72. + T cells into IL-4-secreting cells. J Immunol 1994;152:5180-5188.
73. + T cells in susceptible BALB/c as compared with resistant CBA mice. J Immunol 1986;136:1467-1471.
74. DeTolla LJ, Scott PA, Farrell JP. Single gene control of resistance to cutaneous leishmaniasis in mice. Immunogenetics 1981;14:29-39.
75. Roberts LJ, Baldwin TM, Curtis JM, Handman E, Foote SJ. Resistance to Leishmania major is linked to the H2 region on chromosome 17 and to chromosome 9. J Exp Med 1997;185:1705-1710.
76. Roberts M., Mock BA, Blackwell JM. Mapping of genes controlling Leishmania major infection in CxS recombinant inbred mice. Eur J Immunogenet 1993;20:349-362.